SEC Form 3 · accession 0000899243-16-031625
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pillar Pharmaceuticals V LP
Director · 10% Owner
Period of report
Oct 7, 2016
Accepted (ET)
Oct 12, 2016 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 875,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Youssef El Zein is a director and controlling stockholder of Pillar Invest Corporation, the general partner of Pillar Pharmaceuticals V, L.P. ("Pillar V"), and Mr. El Zein serves as a representative of Pillar V on the Issuer's board of directors. Pillar V may be deemed to be part of a "group" with Pillar Pharmaceuticals I, L.P. Pillar Pharmaceuticals II, L.P., Pillar III, L.P. and Pillar IV, L.P., of which Pillar GP is the general partner of each, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.